HA
HHLR Advisors’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Hold |
6,657,030
| – | – | 0.73% | 14 |
|
|
2025
Q1 | $26.7M | Hold |
6,657,030
| – | – | 0.75% | 15 |
|
|
2024
Q4 | $43.2M | Hold |
6,657,030
| – | – | 1.5% | 14 |
|
|
2024
Q3 | $36.9M | Hold |
6,657,030
| – | – | 0.81% | 15 |
|
|
2024
Q2 | $37.1M | Hold |
6,657,030
| – | – | 0.92% | 13 |
|
|
2024
Q1 | $44.7M | Hold |
6,657,030
| – | – | 0.97% | 16 |
|
|
2023
Q4 | $60.7M | Hold |
6,657,030
| – | – | 1.22% | 15 |
|
|
2023
Q3 | $36.7M | Hold |
6,657,030
| – | – | 0.82% | 17 |
|
|
2023
Q2 | $56.9M | Sell |
6,657,030
-1,046,484
| -14% | -$8.94M | 1.21% | 16 |
|
|
2023
Q1 | $70.8M | Sell |
7,703,514
-981,016
| -11% | -$9.02M | 1.26% | 15 |
|
|
2022
Q4 | $88.7M | Sell |
8,684,530
-72,500
| -0.8% | -$740K | 1.87% | 12 |
|
|
2022
Q3 | $129M | Hold |
8,757,030
| – | – | 3.39% | 9 |
|
|
2022
Q2 | $94M | Hold |
8,757,030
| – | – | 2.01% | 13 |
|
|
2022
Q1 | $94.4M | Hold |
8,757,030
| – | – | 1.97% | 12 |
|
|
2021
Q4 | $143M | Hold |
8,757,030
| – | – | 2.21% | 11 |
|
|
2021
Q3 | $187M | Buy |
+8,757,030
| New | +$187M | 2.45% | 11 |
|